Meanwhile, some of the current to suggest that SG has significant efficacy in the adjuvant treatment of TNBC neoadjuvant or metastatic breast cancer, and also has efficacy in Her-2 negative, ER(+) breast cancer. Here, ESR1 is linked to breast carcinoma.